secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001493152-26-006213
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals to release Q3 FY2026 results Feb 17, host call Feb 18
---------------------------------------------------------------------------

- Q3 FY2026 financial results will be released on Tuesday, February 17, 2026.
- Conference call on Wednesday, February 18, 2026 at 11:30 AM EST.
- Dial-in: 1-800-346-7359 (domestic), 1-973-528-0008 (international), conference code 98840.
- Stockholders may submit general questions by 5 PM EST Feb 16; financial questions by 7 PM EST Feb 17.
- Questions can be emailed to dianne@elitepharma.com.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226006213/0001493152-26-006213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226006213/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-006213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer